Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
National Reconstruction Fund investment mandate released
November 30, 2023 - - AusBiotech -
Clarity’s theranostic prostate cancer trial progresses at the highest dose level cohort
November 30, 2023 - - Latest News -
4DMedical and Philips sign Memorandum of Understanding
November 30, 2023 - - Latest News -
Chimeric Therapeutics provides additional information on vitro data for CHM 1301
November 30, 2023 - - Latest News -
Microba completes stage one screening for its autoimmune disease program
November 30, 2023 - - Latest News -
AusBiotech weighs in on Australia’s RNA future
November 28, 2023 - - AusBiotech -
Federal government backs the development of treatment for childhood brain cancer
November 28, 2023 - - Latest News